SEC Filing Update: #FBRX Forte Biosciences, Inc. : $76.84

Sector: Healthcare | YTD: 🔼+ 225.32% The SEC disclosed Today (14-AUG-2026) that ORBIMED ADVISORS LLC has DECREASED #FBRX Shares by -19.82% 🔴 * Previous Holdings: 1.58M Shares * Current Holdings: 1.26M Shares * Decrease -312.73K * Decreased (%)-19.82% * Ownership: 6.2% https://www.thinksabio.com/reports/isr/FBRX Institutional ownership in #FBRX has been steadily rising over the past 7 quarters in Shares: Q3 2024: 736.63K Q4 2024: 4.28M Q1 2025: 5.03M Q2 2025: 9.81M Q3 2025: 10.34M Q4 2025: 11.52M Q1 2026: 13.52M The quarterly average prices of #FBRX: Q3 2025: $11.53 Q4 2025: $17.40 Q1 2026: $28.82 📌 Institutional activity in the last 30 days for #FBRX: • ALGER ASSOCIATES INC – Increased holdings by 311,228 shares (07-AUG-2026) • GLAZER CAPITAL, LLC – Newly bought 300,000 shares (11-AUG-2026) • JANUS HENDERSON GROUP PLC – Increased holdings by 1,373,060 shares (13-AUG-2026) • BLACKROCK INC – Increased holdings by 1,138,711 shares (28-JUL-2026)